References
- 1. Gallie N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2016;37:67-119.10.1093/eurheartj/ehv31726320113
- 2. Peacock AJ. Primary pulmonary hypertension. Thorax. 1999;54:1107-1118.10.1136/thx.54.12.1107176375010567632
- 3. Jing ZC, Xu XQ, Badesch DB, et al. Pulmonary function testing in patients with pulmonary arterial hypertension. Respir Med. 2009;103:1136-1142.10.1016/j.rmed.2009.03.00919403296
- 4. Sabry AF, El-Hagrasi HF, Hossam H, et al. Changes in pulmonary functions in children in responses to pulmonary hypertension associated with cardiac disease in Suez Canal Area in Egypt. Med J Cairo Univ. 2013;81(2):101-106.
- 5. Meyer FJ, Ewert R, Hoeper MM, et al. Peripheral airway obstruction in primary pulmonary hypertension. Thorax. 2002;57:473-476.10.1136/thorax.57.6.473174634812037220
- 6. Abman SH, Hansmann G, Archer SL, et al. Pediatric Pulmonary Hypertension Guidelines from the American Heart Association and American Thoracic Society. Circulation. 2015;132(21):2037-2099.10.1161/CIR.000000000000032926534956
- 7. Colvin KL, Dufva MJ, Delaney RP, Ivy DD, Stenmark KR, Yeager ME. Biomarkers for pediatric pulmonary arterial hypertension – a call to collaborate. Front Pediatr. 2014;2(7):1-12.10.3389/fped.2014.00007391012524551834
- 8. Ploegstra MJ, Douwes J, Roofthooft MTR, Zijlstra WM, Hillege HL, Berger RM. Identification of treatment goals in paediatric pulmonary arterial hypertension. Eur Respir J. 2014;44:1616-1626.10.1183/09031936.0003041425034572
- 9. American Thoracic Society. American Thoracic Society statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166:111-117.10.1164/ajrccm.166.1.at110212091180
- 10. Laszlo G. Standardisation of lung function testing: helpful guidance from the ATS/ERS Task Force. Thorax. 2006;61(9):744-746.10.1136/thx.2006.061648211709816936234
- 11. Linde LM, Siegel SI, Martelle RR, Simmons DH. Lung function in congenital heart disease. Chest. 1964;46(1):46-5010.1378/chest.46.1.4614195406
- 12. Giaid A, Saleh D. Redeced expression of endothelin nitric oxide synthase in the lungs of patients with pulmonary hypertension. N Engl J Med. 1995;333(4):214-221.10.1056/NEJM199507273330403
- 13. Martin C, Held HD, Uhlig S. Differential effects of the mixed ET(A)/ET(B)-receptor antagonists bosentan on endothelin-induced bronchoconstriction, vasoconstriction and prostacyclin release. Naunyn Schmiedebergs Arch Pharmacol. 2000;362:128-136.10.1007/s002100000264
- 14. Lammers AE, Hislop AA, Flynn Y, et al. The 6-minute walk test: normal values for children of 4-11 years of age. Arch Dis Child. 2008;93:464-468.10.1136/adc.2007.123653
- 15. Nixon PA, Joswiak ML, Fricker FJ. A six-minute walk test for assessing exercise tolerance in severely ill children. J Pediatr. 1996;129:362-366.10.1016/S0022-3476(96)70067-7
- 16. Bernus A, Wagner BD, Accurso F, et al. Brain Natriuretic Peptide Levels in Managing Pediatric Patients with Pulmonary Arterial Hypertension. Chest. 2009;135(3):745-751.10.1378/chest.08-0187271555418849405
- 17. D’Alonzo GE, Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med. 1991;115:343-349.10.7326/0003-4819-115-5-3431863023
- 18. Sultan K, Hussain M, Ismael A. The relation of echocardiographic findings to pulmonary function tests in patients with chronic obstructive pulmonary disease. J Fac Med Baghdad. 2009;51(1):17-22.10.32007/jfacmedbagdad.5111160
- 19. Higham MA, Dawson D, Joshi J, et al. Utility of echocardiography in assessment of pulmonary hypertension secondary to COPD. Eur Respir J. 2001;17:350-355.10.1183/09031936.01.1730350011405510